Patents by Inventor HENRY JOSEPH LEGERE, III

HENRY JOSEPH LEGERE, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10835122
    Abstract: A method for image processing medical self-test results receives a digital image of a visual indication of a test result. A digital image is generated of the visual indication of the test result that includes noise and distortions therein. The digital image is processed using generalized curve field transforms to extract relevant features of the digital image in a presence of the noise and distortions to create a transformed image. A diagnosis is generated based upon the transformed image to the plurality of images of the test results.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: November 17, 2020
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III, Hans Kristian Sandberg
  • Publication number: 20200250389
    Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.
    Type: Application
    Filed: April 22, 2020
    Publication date: August 6, 2020
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20200152339
    Abstract: A system for creating a unique transaction ID (UTID) securely representing a medical diagnostic transaction between a user/patient and a telemedicine professional is provided. The system includes a first central office database configured to store medical information and profile information for a plurality of users/patients, a second central office database configured to store UTIDs, a memory, and a processor coupled to the memory. The processor is configured to receive test information, initiate generation of a UTID for the new diagnostic transaction, analyze the received test information to determine if the test information indicates a positive or a negative result, transfer the analysis results back to the user/patient's MU, and receive from the MU a request for a telemedicine professional session.
    Type: Application
    Filed: November 5, 2019
    Publication date: May 14, 2020
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20200150049
    Abstract: A method for performing a diagnostic test comprises generating a first visual trigger on a display screen of a mobile device responsive to activation of an application on the mobile device. An image of a diagnostic test presently viewed by a camera incorporated with the mobile device is displayed on the display screen of the mobile device. The diagnostic test has a second visual trigger thereon. The image and the first visual trigger are displayed on the display screen at a same time. An image is captured by the application of the diagnostic test responsive to alignment of the first visual trigger with the second visual trigger on the display screen of the mobile device. The captured image is processed to provide test results for the diagnostic test.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 14, 2020
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III
  • Patent number: 10635870
    Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 28, 2020
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 10631031
    Abstract: A system and method are provided for collection and of a biologic sample. The method comprises collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects also include presenting audiovisual messages to the user while the user is waiting for test results to be completed. These audiovisual messages are presented to the user by a mobile application. The audiovisual messages may take several forms, including advertisements and television channels.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: April 21, 2020
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 10527555
    Abstract: A method for performing a diagnostic test comprises generating a first visual trigger on a display screen of a mobile device responsive to activation of an application on the mobile device. An image of a diagnostic test presently viewed by a camera incorporated with the mobile device is displayed on the display screen of the mobile device. The diagnostic test has a second visual trigger thereon. The image and the first visual trigger are displayed on the display screen at a same time. An image is captured by the application of the diagnostic test responsive to alignment of the first visual trigger with the second visual trigger on the display screen of the mobile device. The captured image is processed to provide test results for the diagnostic test.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: January 7, 2020
    Assignee: RELIANT IMMUNE DISGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20190384890
    Abstract: A method for providing immunoassay test results includes collecting at least one biologic with a testing device, conjugating the biologic with particles on a conjugate pad of a test strip to create an immune complex, binding antigens or antibodies of the immune complex to antigens or antibodies of a test line, providing a software application to be stored on a mobile device having a camera; capturing an image of the testing device, including a color mosaic having at least one color value corresponding to a positive test result, comparing the color values of the test line image to the color values of the image of the color mosaic, determining if the color values of the image of the test line are within a predetermined range of the at least one color value of the image of the color mosaic corresponding to a positive test result; and presenting test results on the viewing screen.
    Type: Application
    Filed: June 15, 2018
    Publication date: December 19, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III, NICHOLAS SOLTER, DOGU BARAN AYDOGAN
  • Publication number: 20190376966
    Abstract: A system for providing colorimetric and ratiometric comparison and quantification for medical test results, comprising a testing device including an alignment target and including a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a test line and a control line, and a colorimetry device configured to operate with a mobile device, the mobile device including a camera and a software application stored thereon, wherein the software application provides executable instructions to detect color properties of a color of the test line and a color of a control line of at least one of the plurality of immunoassay test strips, determine a risk value for each of at least one disease risks tested using the biologic sample, wherein the risk value is a rating determined from the color properties of the color of the test line, and provide medical test results based on the risk value.
    Type: Application
    Filed: June 6, 2018
    Publication date: December 12, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190343386
    Abstract: A method for image processing medical self-test results receives a digital image of a visual indication of a test result. A digital image is generated of the visual indication of the test result that includes noise and distortions therein. The digital image is processed using generalized curve field transforms to extract relevant features of the digital image in a presence of the noise and distortions to create a transformed image. A diagnosis is generated based upon the transformed image to the plurality of images of the test results.
    Type: Application
    Filed: May 14, 2018
    Publication date: November 14, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III, HANS KRISTIAN SANDBERG
  • Patent number: 10473659
    Abstract: An immediate health assessment response system, comprising a testing device having thereon an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad capable of receiving a biologic sample, and a server configured to receive information from a mobile device regarding test results from a test performed using the testing device, receive an image from a mobile device, process the image to determine results based on pixel count and line intensity of the test line of each of the plurality of immunoassay test strips, compare the results of processing the image to a control for each test line of each of the plurality of immunoassay test strips, and provide a risk indicator, wherein the risk indicator alerts a user to seek medical attention immediately.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: November 12, 2019
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20190318139
    Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 17, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Patent number: 10331924
    Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 25, 2019
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20190168213
    Abstract: A method for determining a treatment agent and dosage level for a biologic material includes the biologic sample is pumped into each of a first plurality of parallel pathways from the first reservoir using a micro-pump. A separate treatment agent of the plurality of treatment agents is applied within each of the first plurality of parallel pathways. The treatment agent providing a best treatment efficacy for the predetermined biologic material within the biologic sample is determined. A second portion of the biologic sample is pumped into a selected second parallel pathway associated with the determined treatment agent of a second plurality of parallel pathways from the first reservoir using a second micro-pump. The determined treatment agent at a plurality of different dosage levels is applied within the selected second parallel pathway. A dosage level of the plurality of different dosage levels of the determined treatment agent is determined.
    Type: Application
    Filed: November 10, 2018
    Publication date: June 6, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190172591
    Abstract: A method for generating medical trends based on medical test results by a server, comprising obtaining results from a first test related to a medical condition of a first patient, obtaining results from a second test related to a medical condition second patient, wherein the results include patient information and efficacy and dosage level information of a medication, comparing the patient information and the test results of the first patient with the patient information and the test results of the second patient, determining that a patient characteristic of the first patient matches a patient characteristic of the second patient, storing a potential trend, receiving a plurality of additional test results, determining that the potential trend is found in the additional test results in an amount that is above a threshold, and altering the potential trend to an active trend.
    Type: Application
    Filed: November 10, 2018
    Publication date: June 6, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190148013
    Abstract: An artificial intelligence response system comprises a centralized system having associated therewith a trained database, a tends engine, and a plurality of patient records, a plurality of interconnected entities connected over a network to the centralized system, and a voice-activated assistant device connected over the network to the centralized system and to the interconnected entities, the voice-activated assistant device including a memory operatively coupled to a processor, wherein the processor is configured to receive medical information pertaining to a patient's health from the centralized system, request a treatment regimen for the patient from the centralized system, receive a voice command from a medical professional to retrieve additional medical information, request additional medical information in response to the voice command, and request one or more actions related to treating a patient.
    Type: Application
    Filed: November 10, 2018
    Publication date: May 16, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190144914
    Abstract: A system for testing a treatment agent for a biologic material includes an input for receiving a biologic sample. A plurality of micro-pumps pump a portion of the biologic sample from the first reservoir into a connected module. A first module includes a first plurality of testing pathways for testing a first portion of the biologic sample. A first module connector removeably connects the first module to the distributor module. A second module includes a second plurality of testing pathways for testing a second portion of the biologic sample. The selected pathway applies at least one dosage level of a treatment agent to the second portion of the biologic sample. A second module connector removeably connects the second module to the distributor module, wherein treatment agent and the plurality of dosage levels tested by the system may be selected by selecting the second module associated with the second module connector.
    Type: Application
    Filed: November 10, 2018
    Publication date: May 16, 2019
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20190144913
    Abstract: A microfluidic chip system includes an input for receiving the biologic sample, and a first reading window for enabling a detection of the biologic material within the biologic sample. A first plurality of pathways is provided each for determining a treatment agent providing a best treatment efficacy for the predetermined biologic material. A first micro-pump is provided for pumping a portion of the biologic sample into each of the first plurality of pathways. A second plurality of pathways is provided, each for determining a dosage level of a particular one of the plurality of treatment agents with respect to the predetermined biologic material. A plurality of second micro-pumps are provided for pumping a second portion of the biologic sample into a selected one of the second plurality of pathways responsive to the determination of treatment efficacy of the treatment agent providing a best treatment of the predetermined biologic material.
    Type: Application
    Filed: November 10, 2018
    Publication date: May 16, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190148014
    Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.
    Type: Application
    Filed: November 10, 2018
    Publication date: May 16, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190147997
    Abstract: A method for generating a treatment plan in response to medical test results is provided. The method comprises requesting point-of-care (POC) services from a mobile POC unit, receiving at a server confirmation of delivery of POC services to a patient, receiving at the server one or more test results as a result of operation of a medical testing device used in the POC services, wherein the one or more test results includes a determination of the efficacy and dosage level of a medication, generating at the server an updated digital patient record reflecting the one or more test results, and transmitting by the server to a medical entity a treatment plan based on the efficacy and dosage level determined for the medication, wherein the treatment plan is a dosage regimen for the medication.
    Type: Application
    Filed: November 14, 2018
    Publication date: May 16, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III